COMMENTARY

• COMMENTARY／Japan Needs to Create Attractive "Stadium for Drug Discovery" and Invite Top-Level Players
  February 25, 2008

• COMMENTARY／Revision of Medical Fees May Increase Use of Drugs for Stroke, Mental Illnesses, Cancer
  February 11, 2008

• Current New Drug Development in the Japanese Pharmaceutical Industry（2）
  February 11, 2008

• Current New Drug Development in the Japanese Pharmaceutical Industry（1）
  February 11, 2008

• COMMENTARY／Generic Makers Increase Investment, but Will Consumption Really Increase as Gov't Hopes？
  February 4, 2008

• COMMENTARY／Full-Scale M&As Imminent among Dispensing Pharmacy Chains
  January 28, 2008

• OPINION／The East versus West Dilemma
  January 28, 2008

• COMMENTARY／Full-Scale M&As Imminent among Dispensing Pharmacy Chains
  January 28, 2008

• No More Need for MRs？ -A Hell beyond the 2010 Crisis？-
  January 14, 2008

• COMMENTARY／Year 2007 in Retrospect
  December 24, 2007

• COMMENTARY／Appreciation Mixed with Concern: Proposed NHI Pricing Reform
  December 17, 2007

• COMMENTARY／Fight over Medical Fee/NHI Price Revision Rates Begin
  December 3, 2007

• COMMENTARY：Korosho Must Explain Its "Primary Doctor" System Proposal in Detail
  October 1, 2007

• Gakkai, Specialty Certification and Industry by Mark Colby
  September 10, 2007

• COMENTARY：Korosho Required to Cut \220 Bil. in Social Security Spending
  September 3, 2007

• COMMENTARY／NHI Drug Pricing System Reform: Many Similarities in Proposals from JPMA, PhRMA, EFPIA
  August 27, 2007

• COMMENTARY／Range of Drugs Re-priced due to Expansion of Market May Be Expanded
  July 23, 2007

• COMMENTARY／Market for Osteoporosis Drugs Booms
  July 9, 2007

• COMMENTARY／Pressure Mounting on Long-Listed Original Drugs
  July 9, 2007

• COMMENTARY：Generic Firms Need Stronger Business Platform to Ensure Nationwide Stable Supply
  June 25, 2007

ページ

• « 先頭
• ‹ Prev
• …
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• …
• Next ›
• 最終 »